<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Granulocyte-colony stimulating factor (G-CSF) is reported to be neuroprotective after transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> with respect to decreasing lesion volume and enhancing functional recovery </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether G-CSF is neuroprotective after permanent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and the possible mechanisms underlying this neuroprotection </plain></SENT>
<SENT sid="2" pm="."><plain>Mice underwent permanent or 60-minute middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and received G-CSF (50 microg/kg) or vehicle at the <z:hpo ids='HP_0003674'>onset</z:hpo> or 1 hour post-MCAO </plain></SENT>
<SENT sid="3" pm="."><plain>Forty-eight hours after transient MCAO, structural magnetic resonance imaging revealed a significant reduction (50%) in the amount of edematous tissue present in G-CSF-treated mice (p &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>G-CSF treatment also prevented a significant increase in ipsilateral brain water content that was present in vehicle-treated mice after transient (p &lt; 0.05) and permanent (p &lt; 0.001) MCAO </plain></SENT>
<SENT sid="5" pm="."><plain>Forty-eight hours after permanent MCAO, G-CSF decreased (50%) the cortical lesion volume (p &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Using real-time polymerase chain reaction, we found that G-CSF treatment significantly suppressed (p &lt; 0.05) the injury-induced upregulation of IL-1beta <z:chebi fb="2" ids="33699">mRNA</z:chebi> while having no effect on TNFalpha and NOS-2 mRNA expression </plain></SENT>
<SENT sid="7" pm="."><plain>This suggests that part of the neuroprotection may be attributed to the ability of G-CSF to reduce the <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
</text></document>